Edition:
United States

ViroMed Co Ltd (084990.KQ)

084990.KQ on KOSDAQ - Korea Secs Dealers Association Quotation

115,900.00KRW
22 Sep 2017
Change (% chg)

₩-1,200.00 (-1.02%)
Prev Close
₩117,100.00
Open
₩117,600.00
Day's High
₩118,000.00
Day's Low
₩112,400.00
Volume
93,113
Avg. Vol
144,296
52-wk High
₩146,700.00
52-wk Low
₩83,500.00

Chart for

About

ViroMed Co., Ltd. is a Korea-based company engaged in the development and manufacture of new biopharmaceuticals and reagents. The Company produces protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs, natural pharmaceuticals and others, which are used for therapy of various diseases, including cardiovasc... (more)

Overall

Beta: 1.29
Market Cap(Mil.): ₩1,884,434.00
Shares Outstanding(Mil.): 15.96
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 78.94 16.33
EPS (TTM): -- -- --
ROI: -- 2.84 14.66
ROE: -- 4.61 13.99

BRIEF-ViroMed receives patent

* Says it received patent on Sep. 13, for composition for preventing or treating amyotrophic lateral sclerosis using two or more isoforms of hepatocyte growth factor

Sep 14 2017

BRIEF-ViroMed receives patent

* Says it receives patent about composition for Preventing or Treating Peripheral Artery Disease Using Hepatocyte Growth Factor and Stromal Cell Derived Factor 1 alpha

Jul 04 2017

Earnings vs. Estimates